Page 8 of 8
Organisation
Study Identifier
(Website)
European Medicines Agency
2018-001316-29 1
(www.clinicaltrialsregister.eu)
United States National Institutes of Health (NIH)
NCT05553808 2
(www.clinicaltrials.gov)
The scientific summaries include more details about the requirements for study enrolment,
the study visit schedule, results from other endpoints, and more detailed information about
adverse events. These details will be available on the above link on Clinicaltrials.gov by
November 2022.
Your doctor can help you understand more about this study and the results. You
should not make changes to your care based on the results of this or any single
study.
We would like to thank the participants who contributed to this study. The results of
this study will help answer scientific questions about treating participants with advanced
NSCLC.
The content for this document was finalised by GSK on 20 July 2022. The information in this
summary does not include additional information available after this date.
1https://www.clinicaltrialsregister.eu/ctr-search/search?query=205801
2https://clinicaltrials.gov/ct2/show/NCT05553808?term=NCT05553808